Ghent University Academic Bibliography

Your filters: cql: author="Martín, Miguel" or (type any "bookEditor issueEditor" and editor="Martín, Miguel")

Add to list
- Journal Article
- A1
- open access
Microplastics occurrence and fate in full-scale treatment wetlands

Darío Calzadilla Cabrera, Qintong Wang (UGent) , Miguel Martín, Nuria Oliver Rajadel, Diederik Rousseau (UGent) and Carmen Hernández-Crespo

(2023) WATER RESEARCH. 240.
Add to list
- Journal Article
- A2
- open access
Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey (UGent) , Daniele Generali, et al.

(2021) JCO GLOBAL ONCOLOGY. 7. p.162-172
Add to list
- Journal Article
- A1
- open access
Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lueftner, Sylvie Rottey (UGent) , Peter A. van Dam, et al.

(2021) CANCERS. 13(17).
Add to list
- Journal Article
- A1
- open access
Oncological care organisation during COVID-19 outbreak

Concetta Elisa Onesti, Hope S. Rugo, Daniele Generali, Marc Peeters, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Miguel Martin, Massimo Cristofanilli, Javier Cortes, et al.

(2020) ESMO OPEN. 5(4).
Add to list
- Conference Paper
- C3
Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple negative breast cancer (TNBC) or colorectal cancer (CRC).

J. Randolph Hecht, Arlene Chan, Miguel Martin, Nicolas Mach, Sara A. Hurvitz, Sylvie Rottey (UGent) , Uwe Pelzer, Chunxu Liu and Emily Chan

(2019) JOURNAL OF CLINICAL ONCOLOGY. 37(4).

Academic Bibliography

Microplastics occurrence and fate in full-scale treatment wetlands

Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Oncological care organisation during COVID-19 outbreak

Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple negative breast cancer (TNBC) or colorectal cancer (CRC).

Contents

Support

Contact